AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
251.98
-5.43 (-2.11%)
Jul 31, 2026, 1:12 PM EDT - Market open
AbbVie Stock Forecast
Stock Price Forecast
According to 31 analysts polled by S&P Global, AbbVie stock has a consensus rating of "Buy" and an average price target of $268.68. The average 1-year stock price forecast is 6.63% higher than the current stock price, while the lowest is $200 (-20.63%) and the highest is $328 (+30.17%).
Price Target: $268.68 (+6.63%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for AbbVie stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 13 | 14 | 16 | 16 | 16 | 16 |
| Buy | 8 | 8 | 8 | 8 | 8 | 8 |
| Hold | 9 | 9 | 8 | 8 | 6 | 6 |
| Sell | 1 | 0 | 0 | 0 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 31 | 31 | 32 | 32 | 31 | 31 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $280 | Buy | Maintains | $280 | +11.12% | Jul 31, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $234 → $276 | Buy | Maintains | $234 → $276 | +9.53% | Jul 31, 2026 |
| Barclays | Barclays | Buy Maintains $275 → $300 | Buy | Maintains | $275 → $300 | +19.06% | Jul 29, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $298 | Buy | Reiterates | $298 | +18.26% | Jul 28, 2026 |
| Bernstein | Bernstein | Hold Maintains $225 | Hold | Maintains | $225 | -10.71% | Jul 23, 2026 |
Financial Forecast
Revenue This Year
67.27B
from 61.16B
Increased by 9.99%
Revenue Next Year
72.86B
from 67.27B
Increased by 8.30%
EPS This Year
14.12
from 10.00
Increased by 41.16%
EPS Next Year
16.30
from 14.12
Increased by 15.44%
EPS and Forward PE are based on non-GAAP adjusted numbers.